BioFactura Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioFactura Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011823
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioFactura Inc (Biofactura) is a biosimilars manufacturer that discovers, develops and markets biodefense drugs and client selected novel drugs. The company offers contract services such as process development, stable cell lines, and manufacturing. Its stable cell lines offers stable mammalian cell line development for high titer, scalable manufacture of monoclonal antibodies and recombinant proteins. Biofactura’s biodefence products include smallpox therapeutic, and ebola sudan therapeutic. The company utilizes its stablefast biomanufacturing platform, which is a novel system to generate stable NS0 cell lines for biopharmaceutical manufacturing. It serves biodefense and non-biodefense markets. Biofactura is headquartered in Frederick, Maryland, the US.

BioFactura Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioFactura Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioFactura Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BioFactura Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BioFactura Raises USD1.8 Million in Series A Financing 10
Partnerships 11
BioFactura Partners with Geneva Foundation 11
Noble Life Sciences Partners with BioFactura 12
Licensing Agreements 13
Vivalis Enters Into Licensing Agreement With Biofactura For EB66 Cell Line 13
BioFactura Inc – Key Competitors 14
BioFactura Inc – Key Employees 15
BioFactura Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BioFactura Inc, Pharmaceuticals & Healthcare, Key Facts 2
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioFactura Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioFactura Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioFactura Inc, Deals By Therapy Area, 2011 to YTD 2017 8
BioFactura Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BioFactura Raises USD1.8 Million in Series A Financing 10
BioFactura Partners with Geneva Foundation 11
Noble Life Sciences Partners with BioFactura 12
Vivalis Enters Into Licensing Agreement With Biofactura For EB66 Cell Line 13
BioFactura Inc, Key Competitors 14
BioFactura Inc, Key Employees 15

★海外企業調査レポート[BioFactura Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crown Bioscience Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Crown Bioscience Inc. (Crown Bioscience) is a pharmaceutical company that provides drug discovery and development services. The company offers in vivo and in vitro research reagents. It provides preclinical contract research services in the areas of oncology and metabolic disease. Crown Bios …
  • Dana-Farber Cancer Institute Inc-医療機器分野:企業M&A・提携分析
    Summary Dana-Farber Cancer Institute Inc (Dana-Farber), formerly Sidney Farber Cancer Center is a cancer research center that offers treatment for different types of cancers. The center offers adults and children with various treatment options and also focuses on diagnosis, treatment, cure, and prev …
  • Charleston Area Medical Center Health System, Inc.(製薬・医療分野):企業M&A動向
    Summary Charleston Area Medical Center Health System, Inc. (CAMC Health System) is a healthcare service provider. The company focuses on behavioral health services, cardiac service, challenged sport, craniofacial surgery, diabetes education program for outpatients, facial surgery, imaging services, …
  • All in West! Capital Corporation:企業の戦略・SWOT・財務分析
    SummaryAll in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Corgi International Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Corgi International Limited Mer …
  • National Wine and Spirits, Inc.:企業の戦略・SWOT・財務分析
    SummaryNational Wine and Spirits, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • ITOCHU Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ITOCHU Corporation Mergers and …
  • The Techint Groupの企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "The Techint Group" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence …
  • Descon Oxychem Limited (DOL):企業財務及び戦略的SWOT分析
    Summary Descon Oxychem Limited (Descon Oxychem) is a chemical company that offers hydrogen peroxide properties. The company offers services such as engineering and applied technology services. Its engineering services include safety training, pre-delivery inspections, design assistance, basic and de …
  • Abu Dhabi National Oil Company:企業のM&A・提携動向(石油・ガス分野)
    Summary Abu Dhabi National Oil Company (ADNOC) is a vertically integrated national oil and gas group. The group is active in exploration and production, support services, oil refining and gas processing, chemicals and petrochemicals, maritime transportation and refined products and distribution. ADN …
  • S.C. Hidroelectrica S.A.:企業のM&A・提携動向(エネルギー分野)
    Summary S.C. Hidroelectrica S.A. (Hidroelectrica) is a power generation company. It generates electricity through renewable sources of energy, particularly hydro. The company is a leading power generator and provider of ancillary services to customers in the Romania. It operates across Romania throu …
  • Interwaste Holdings Limitedの企業概要及び財務/SWOT分析
    Interwaste Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Interwaste Holdings Limited annual and quarterly forecasts made by stock market experts. The repor …
  • UDG Healthcare plc (UDG):企業の財務及び戦略的SWOT分析
    UDG Healthcare plc (UDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Oil Basins Limited (OBL)(石油・ガス分野):企業M&A動向
    Summary Oil Basins Limited (Oil Basins) is an oil and gas exploration company. The company develops, explores and produces crude oil and natural gas. It explores its products in offshore Gippsland Basin waters of south-eastern Australia, onshore Canning Basin of Western Australia, and offshore Carna …
  • Kofola S.A.:企業の戦略・SWOT・財務分析
    SummaryKofola S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Enbridge Inc. (ENB):企業のM&A・提携動向(石油・ガス分野)
    Summary Enbridge Inc. (Enbridge) is an integrated energy company. It conducts gathering, processing and transmission of natural gas; transportation of crude oil; natural gas distribution; and markets petroleum products. The company also has interests in renewable and green energy technologies includ …
  • Keyang Electric Machinery Co., Ltd.の企業概要及び財務/SWOT分析
    Keyang Electric Machinery Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual …
  • DaChan Food (Asia) Limited:企業の戦略・SWOT・財務分析
    SummaryDaChan Food (Asia) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Sterling Financial Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sterling Financial Corporation …
  • KM Corporation (083550):企業財務及び戦略的SWOT分析
    Summary KM Corporation (KM) is a medical device company that manufactures and markets disposable products. The company provides clean-room products, industrial goods and garments. Its clean-room and industrial products comprise gloves, wipers, stationery, cleaners, respirators, eye, ear and skin saf …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆